SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-015106
Filing Date
2024-05-07
Accepted
2024-05-07 16:29:36
Documents
88
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q opk20240331c_10q.htm   iXBRL 10-Q 1866075
2 EXHIBIT 3.1 ex_667413.htm EX-3.1 116575
3 EXHIBIT 31.1 ex_638079.htm EX-31.1 12381
4 EXHIBIT 31.2 ex_638080.htm EX-31.2 12303
5 EXHIBIT 32.1 ex_638081.htm EX-32.1 3884
6 EXHIBIT 32.2 ex_638082.htm EX-32.2 3789
  Complete submission text file 0001437749-24-015106.txt   10923584

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA opk-20240331.xsd EX-101.SCH 85667
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opk-20240331_cal.xml EX-101.CAL 67994
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20240331_def.xml EX-101.DEF 699565
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20240331_lab.xml EX-101.LAB 561215
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20240331_pre.xml EX-101.PRE 738342
92 EXTRACTED XBRL INSTANCE DOCUMENT opk20240331c_10q_htm.xml XML 1854813
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 24922445
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)